Precision Medicine for Advanced Pancreas Cancer: The Individualized Molecular Pancreatic Cancer Therapy (IMPaCT) Trial
Lorraine A Chantrill, Adnan M Nagrial, Clare Watson, Amber L Johns, Mona Martyn-Smith, Skye Simpson, Scott Mead, Marc D Jones, Jaswinder S Samra, Anthony J Gill, Nicole Watson, Venessa T Chin, Jeremy L Humphris, Angela Chou, Belinda Brown, Adrienne Morey, Marina Pajic, Sean M Grimmond, David K Chang, David Thomas Show all
Clinical Cancer Research | AMER ASSOC CANCER RESEARCH | Published : 2015
Awarded by National Health and Medical Research Council of Australia (NHMRC)
Awarded by Cancer Council NSW
Awarded by Cancer Institute NSW
Awarded by Cancer Research UK
This study was supported by the National Health and Medical Research Council of Australia (NHMRC; 631701, 535903, 427601); Cancer Council NSW (grant numbers SRP06-01, SRP11-01); Avner Nahmani Pancreatic Cancer Foundation; Cancer Institute NSW(grant numbers 06/ECF/1-24, 09/CDF/2-40, 07/CDF/1-03, 10/CRF/1-01, 08/RSA/1-15, 07/CDF/1-28, 10/CDF/2-26,10/FRL/2-03, 06/RSA/1-05, 09/RIG/1-02, 10/TPG/1-04, 11/REG/1-10, and 11/CDF/3-26); R.T. Hall Trust; Petre Foundation; Philip Hemstritch Foundation; and Sydney Catalyst, University of Sydney, Australia.